Novartis Commitment to Clinical Trial Research in the UK 

Clinical research represents a fundamental part of our ambition to help people in the UK and around the world who live with many different conditions to improve and extend their lives. In this webinar you can hear more from the Novartis UK clinical research team about our commitment to clinical trial research and how you can partner with us as clinical investigators.




Novartis Commitment to Research, Development & Partnerships 

In this webinar, Dr Samin Saeed, Chief Scientific Officer and Medical Director, Novartis UK, discusses Novartis’ commitment to research and development in the UK and our approach to partnering and fostering innovation with the scientific community.


Rate this content: 
No votes yet
UK | July 2021 | 137640

Ask Speakers


Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]